Medpace Holdings
Stock Forecast, Prediction & Price Target
Medpace Holdings (MEDP) stock Price Target by analysts
$349
Potential downside: -26.05%
Medpace Holdings price prediction
What is Medpace Holdings stock analysts` prediction?
Medpace Holdings stock forecast: Based on 1 Wall Street analysts` predicted price targets for Medpace Holdings in the last 3 months, the avarage price target is $349, with a high forecast of $NaN. The average price target represents a -26.05% change from the last price of $472.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Medpace Holdings stock Price Target by analysts
Full breakdown of analysts given Medpace Holdings price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Eric Coldwell Robert W. Baird | 0% 0/3 | 11 months ago | $349 -26.05% downside | $326.54 | StreetInsider | Previous targets (2) |
David Windley Jefferies | 0% 0/2 | about 1 year ago | $345 -26.90% downside | $355.82 | TheFly | Previous targets (1) |
Jailendra Singh Truist Financial | 0% 0/1 | about 1 year ago | $415 -12.07% downside | $382.52 | TheFly | Previous targets (0) |
Eric Coldwell Robert W. Baird | 0% 0/3 | about 1 year ago | $469 -0.63% downside | $404.13 | StreetInsider | Previous targets (2) |
Eric Coldwell Robert W. Baird | 0% 0/3 | over 1 year ago | $456 -3.38% downside | $403.74 | StreetInsider | Previous targets (2) |
Ann Hynes Mizuho Securities | 0% 0/1 | over 1 year ago | $435 -7.83% downside | $390.55 | StreetInsider | Previous targets (0) |
David Windley Jefferies | 0% 0/2 | over 1 year ago | $450 -4.66% downside | $376.26 | StreetInsider | Previous targets (1) |
John Sourbeer UBS | 0% 0/1 | over 1 year ago | $452 -4.23% downside | $394.34 | StreetInsider | Previous targets (0) |
Medpace Holdings Financial Estimates
Medpace Holdings Revenue Estimates
Medpace Holdings EBITDA Estimates
Medpace Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.14B N/A | $1.45B 27.80% | $1.88B 29.16% | Avg: $2.52B Low: $2.47B High: $2.56B avg. 33.71% | Avg: $2.90B Low: $2.86B High: $2.93B avg. 15.25% | Avg: $3.34B Low: $3.29B High: $3.38B avg. 15.09% | Avg: $4.14B Low: $4.08B High: $4.19B avg. 24.01% |
Net Income
% change YoY
| $181.84M N/A | $245.36M 34.93% | $282.81M 15.25% | Avg: $421.90M Low: $406.42M High: $428.26M avg. 49.18% | Avg: $493.39M Low: $463.72M High: $535.04M avg. 16.94% | Avg: $567.78M Low: $556.15M High: $575.56M avg. 15.07% | Avg: $700.18M Low: $685.83M High: $709.77M avg. 23.31% |
EBITDA
% change YoY
| $219.73M N/A | $301.03M 37.00% | $363.15M 20.63% | Avg: $488.36M Low: $478.59M High: $496.17M avg. 34.47% | Avg: $562.86M Low: $553.99M High: $568.79M avg. 15.25% | Avg: $647.82M Low: $637.61M High: $654.65M avg. 15.09% | Avg: $803.40M Low: $790.73M High: $811.86M avg. 24.01% |
EPS
% change YoY
| $5.06 N/A | $7.57 49.60% | $9.2 21.53% | Avg: $13.14 Low: $12.76 High: $13.45 avg. 42.84% | Avg: $15.46 Low: $14.56 High: $16.8 avg. 17.63% | Avg: $17.83 Low: $17.47 High: $18.08 avg. 15.35% | Avg: $21.99 Low: $21.54 High: $22.29 avg. 23.31% |
Operating Expenses
% change YoY
| $129.54M N/A | $153.74M 18.68% | $187.68M 22.07% | Avg: $242.38M Low: $237.53M High: $246.26M avg. 29.14% | Avg: $279.36M Low: $274.95M High: $282.30M avg. 15.25% | Avg: $321.53M Low: $316.46M High: $324.91M avg. 15.09% | Avg: $398.74M Low: $392.45M High: $402.94M avg. 24.01% |
FAQ
What is Medpace Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 26.13% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is 406.42M, average is 421.90M and high is 428.26M.
What is Medpace Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 22.01% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $2.47B, average is $2.52B and high is $2.56B.
What is Medpace Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 24.78% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is $12.76, average is $13.14 and high is $13.45.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Medpace Holdings stock. The most successful analyst is Eric Coldwell.